Invention Grant
- Patent Title: Tissue matrix materials and enzymatic adhesives
-
Application No.: US15882374Application Date: 2018-01-29
-
Publication No.: US10940184B2Publication Date: 2021-03-09
- Inventor: Eric Stec , Ming F. Pomerleau , Rick T. Owens , Richard Seeman
- Applicant: LifeCell Corporation
- Applicant Address: US NJ Branchburg
- Assignee: LifeCell Corporation
- Current Assignee: LifeCell Corporation
- Current Assignee Address: US NJ Branchburg
- Agency: McCarter & English, LLP
- Main IPC: A61K38/39
- IPC: A61K38/39 ; A61L27/36 ; A61L27/34 ; A61L24/10 ; A01N1/02 ; A61K35/18 ; A61K48/00 ; C12N9/10 ; A61L27/24
Abstract:
The present application relates to use of transglutaminases to treat various tissue matrix products. The methods can include application of a transglutaminase to a partially denatured collagen-containing tissue matrix and implantation of the tissue matrix. The transglutaminase can facilitate adhesion with another collagen-containing tissue matrix, tissue surrounding the tissue matrix after implantation, or both.
Public/Granted literature
- US20180214520A1 TISSUE MATRIX MATERIALS AND ENZYMATIC ADHESIVES Public/Granted day:2018-08-02
Information query
IPC分类:
